189 related articles for article (PubMed ID: 22339843)
1. [An interpretation of expert panel consensus statement on prevention and treatment of anthracycline cardiotoxicity].
;
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):727-8. PubMed ID: 22339843
[No Abstract] [Full Text] [Related]
2. Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities.
Vejpongsa P; Yeh ET
J Am Coll Cardiol; 2014 Sep; 64(9):938-45. PubMed ID: 25169180
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of anthracycline-induced cardiotoxicity.
Jannazzo A; Hoffman J; Lutz M
Ann Pharmacother; 2008 Jan; 42(1):99-104. PubMed ID: 18094345
[TBL] [Abstract][Full Text] [Related]
4. Genotyping the risk of anthracycline-induced cardiotoxicity.
Deng S; Wojnowski L
Cardiovasc Toxicol; 2007; 7(2):129-34. PubMed ID: 17652817
[TBL] [Abstract][Full Text] [Related]
5. Managing anthracycline-induced cardiotoxicity: beginning with the end in mind.
Salvatorelli E; Menna P; Minotti G
Future Cardiol; 2015 Jul; 11(4):363-6. PubMed ID: 26239550
[No Abstract] [Full Text] [Related]
6. Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity.
Chung WB; Youn HJ
Korean J Intern Med; 2016 Jul; 31(4):625-33. PubMed ID: 27378126
[TBL] [Abstract][Full Text] [Related]
7. Anthracycline cardiotoxicity in long-term survivors of childhood cancer.
Scully RE; Lipshultz SE
Cardiovasc Toxicol; 2007; 7(2):122-8. PubMed ID: 17652816
[TBL] [Abstract][Full Text] [Related]
8. An introduction to the metabolic determinants of anthracycline cardiotoxicity.
Menna P; Recalcati S; Cairo G; Minotti G
Cardiovasc Toxicol; 2007; 7(2):80-5. PubMed ID: 17652809
[TBL] [Abstract][Full Text] [Related]
9. Cardiotoxicity and anthracyclines.
Stebbing J; Jones A; Barrett-Lee P
Breast Cancer Res Treat; 2008 Feb; 107(3):451-3. PubMed ID: 18167621
[No Abstract] [Full Text] [Related]
10. [Prevention of cardiotoxic effects of anthracyclines in oncopediatric praxis].
Safonova SA; Gershanovich ML; Punanov IuA
Vopr Onkol; 2006; 52(5):590-2. PubMed ID: 17168373
[No Abstract] [Full Text] [Related]
11. Other uses of dexrazoxane: Savene, the first proven antidote against anthracycline extravasation injuries.
Langer SW; Jensen PB; Sehested M
Cardiovasc Toxicol; 2007; 7(2):151-3. PubMed ID: 17652821
[TBL] [Abstract][Full Text] [Related]
12. [Late-onset anthracycline-induced cardiotoxicity].
Pérez C; Agustí MA; Tornos P
Med Clin (Barc); 2009 Sep; 133(8):311-3. PubMed ID: 19501849
[No Abstract] [Full Text] [Related]
13. Subendocardial late gadolinium enhancement in two patients with anthracycline cardiotoxicity following treatment for Ewing's sarcoma.
Perel RD; Slaughter RE; Strugnell WE
J Cardiovasc Magn Reson; 2006; 8(6):789-91. PubMed ID: 17060100
[TBL] [Abstract][Full Text] [Related]
14. Role of anthracyclines in the era of targeted therapy.
Cortés-Funes H; Coronado C
Cardiovasc Toxicol; 2007; 7(2):56-60. PubMed ID: 17652804
[TBL] [Abstract][Full Text] [Related]
15. Long-term and short-term models for studying anthracycline cardiotoxicity and protectors.
Robert J
Cardiovasc Toxicol; 2007; 7(2):135-9. PubMed ID: 17652818
[TBL] [Abstract][Full Text] [Related]
16. [One case report of a late cardiotoxicity after administration of low doses of anthracyclines].
Lawson L; Masmoudi K; Fry P; Andrejak M
Therapie; 2010; 65(3):269-70. PubMed ID: 20699083
[No Abstract] [Full Text] [Related]
17. Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk.
Barrett-Lee PJ; Dixon JM; Farrell C; Jones A; Leonard R; Murray N; Palmieri C; Plummer CJ; Stanley A; Verrill MW
Ann Oncol; 2009 May; 20(5):816-27. PubMed ID: 19153118
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy-induced cardiotoxicity: Incidence, diagnosis and prevention].
Nelson-Veniard M; Thambo JB
Bull Cancer; 2015; 102(7-8):622-6. PubMed ID: 25935231
[TBL] [Abstract][Full Text] [Related]
19. Anthracycline cardiotoxicity.
Jones RL; Swanton C; Ewer MS
Expert Opin Drug Saf; 2006 Nov; 5(6):791-809. PubMed ID: 17044806
[TBL] [Abstract][Full Text] [Related]
20. New iron chelators in anthracycline-induced cardiotoxicity.
Kaiserová H; Simunek T; Sterba M; den Hartog GJ; Schröterová L; Popelová O; Gersl V; Kvasnicková E; Bast A
Cardiovasc Toxicol; 2007; 7(2):145-50. PubMed ID: 17652820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]